Skip to main content
. 2024 Apr 26;72:102612. doi: 10.1016/j.eclinm.2024.102612

Table 1.

Setting and population characteristics.a

Characteristic N = 192a %a
World Health Organisation (WHO) Region and Country
 Africa 92 47.9
 Americas 32 16.6
 Eastern Mediterranean 10 5.2
 Europe 8 4.1
 Southeast Asia 33 17.2
 Western Pacific 38 19.8
Country income group
 Low 38 19.8
 Lower-Middle 97 50.5
 Upper-Middle 74 38.5
Stigma context
 Alcohol and drug use 6 3.1
 Disabilities 6 3.1
 Ethnicity/Race/Religion 11 5.7
 Gender, Sexuality &Women's healthb 12 6.3
 HIV/AIDSc 104 54.2
 Leprosy 4 2.1
 Mental health 46 24.0
 Tuberculosis 4 2.1
 COVID 19d 1 0.5
Target populatione
 Caregivers of people living with stigmatised conditions 11 5.7
 Children and adolescents 25 13.0
 College and university students 12 6.3
 Criminal justice professionals 2 1.0
 Community leaders 4 2.1
 General population 50 26.0
 Health professionals 58 30.2
 High risk groupsf 12 6.3
 People living with stigmatised conditions 23 12.0
 Academic researchers 1 0.5
 Survivors and perpetrators of genocide 2 1.0
 Teachers 7 3.6
a

Some included studies were conducted in multiple countries and WHO regions, and which belonged to different income groups, or addressed more than one stigma contexts. Therefore, not all counts and percentages will add up to 100%.

b

Women's health includes studies on FGM, female birth attendants etc.

c

Human Immunodeficiency Virus (HIV) and Acquired Immune Deficiency Syndrome (AIDS).

d

Coronavirus Disease 2019.

e

Some studies had more than one target population group.

f

Included: sex workers, market vendors, the military.